A pharmaceutical composition adapted for use in the therapy of helicobacter pylori infection comprising allylamines

摘要

PCT No. PCT/EP96/02970 Sec. 371 Date Jan. 6, 1998 Sec. 102(e) Date Jan. 6, 1998 PCT Filed Jul. 5, 1996 PCT Pub. No. WO97/02026 PCT Pub. Date Jan. 23, 1997Use of compounds of formula (I), wherein R has various significances, in free base form or in pharmaceutically acceptable salt form, as agents against H. pylori infection and associated diseases.